Field Report: Chronic disease management and multi-sector solutions for health-induced poverty are working, but China’s big hospitals are holding back primary care

Dinda Elliott, Executive Director of the Fairbank Center for Chinese Studies, shares insights from Dr. Winnie Yip, Faculty Director of the Harvard China Health Partnership, regarding China’s rural healthcare improvements and health-related poverty elimination. These observations were drawn from Dr. Yip’s field visit to rural villages in Yunnan, China this spring. Read more in the new field report here.

New Publication: Estimating causal effects of physical disability and number of comorbid chronic diseases on risk of depressive symptoms in an elderly Chinese population: a machine learning analysis of cross-sectional baseline data from the China longitudinal ageing social survey

Summary Objective This study aimed to explore the causal effects of physical disability and number of comorbid chronic diseases on depressive symptoms in an elderly Chinese population. Methods Cross-sectional, baseline data were obtained from the China Longitudinal Ageing Social Survey, a stratified, multistage, probabilistic sampling survey conducted in 2014 that covers 28 of 31 provincial areas in China. 7496 subjects who were 60 years of age or older and who…

New Publication: Understanding Impacts of Online Dual Practice on Health System Performance: A Qualitative Study in China

Abstract The outbreak of the COVID-19 pandemic has boosted the global development of online healthcare platforms. An increasing number of public hospital doctors are providing online services on private third-party healthcare platforms, creating a new form of dual practice—online dual practice. To explore the impacts of online dual practice on health system performance as well as potential policy responses, we undertook a qualitative approach that uses in-depth interviews and thematic…

New Publication: The ‘medical city’ and China’s entrepreneurial state: Spatial production under rising consumerism in healthcare

Abstract The role of hospitals has significantly changed over the past decades and the ‘medical city’ has emerged as a new urban phenomenon in China. However, research on the significance of the medical city to China’s urbanism is limited. This paper situates China’s medical city in the theory of state entrepreneurialism and rethinks consumerism in healthcare. Particularly focussing on the state–market and production–consumption dyads, the paper argues that the state…

New Publication: Medical institutions in the geography of innovation: evidence from public tertiary hospitals and biotech start-ups in Chinese cities

Abstract Concerning China’s growth in biotechnology, the research on biotech start-ups in China yields significant implications. However, studies have not given enough attention to hospitals, which are critical players in the biotech industry. Because of the hospital-centric healthcare system, public tertiary hospitals in China are important partners for biotech start-ups. This study investigates the geographical relationship between public tertiary hospitals and biotech start-ups in Chinese cities. The findings suggest evidence…

New Publication: Third-child fertility intention and its socioeconomic factors among women aged 20–34 years in China

Summary Background The low birth rates and rapid population aging has drawn considerable attention in China. In 2021, China launched the policy and supportive measures that allow up to 3 children per couple. This study aims to explore the influencing factors of the third-child fertility intention among women aged 20–34 years in China. Methods We draw data from the National Fertility Survey conducted in 2017. The nationally representative survey adopts…

New Publication: Expanding outpatient benefits package can reduce diabetes-related avoidable hospitalizations

Summary Background China has the largest number of diabetic patients in the world. The total number of adults with diabetes in mainland China is estimated to be 140.9 million, with an estimated 174.4 million in 2045 and an adult prevalence of 13.0 %. In 2021, diabetes-related health costs in China are as high as $165.3 billion, and the prevalence of diabetes in China continues to grow. If patients have access…

New Publication: Understanding medical corruption in China: a mixed-methods study

Abstract Medical corruption is a significant obstacle to achieving health-related Sustainable Development Goals. However, the understanding of medical corruption is limited, especially in developing countries. As the largest developing country, China is also plagued by medical corruption. By employing a mixed-methods design and combining data from three resources, this study attempts to examine patterns of medical corruption in China, explore its key drivers and investigate the perceived effectiveness of recent…

China’s New Health Insurance Policies: A More Equitable System?

Recent reforms to health insurance policies in China have sparked protests in the cities of Wuhan and Dalian, with a majority of protesters being elderly people. Dr. Winnie Yip, Professor of Global Health Policy and Economics, spoke with reporters at NBC News to discuss how these reforms will affect China’s population, particularly its vulnerable groups. The primary concern of protestors is that allocating more employers’ health insurance contributions from individual…

New Publication: The relationship between hospital ownership, in-hospital mortality, and medical expenses: an analysis of three common conditions in China

Summary Background Private hospitals expanded rapidly in China since 2009 following its national health reform encouraging private investment in the hospital sector. Despite long-standing debates over the performance of different types of hospitals, empirical evidence under the context of developing countries remains scant. We investigated the disparities in health care quality and medical expenses among public, private not-for-profit, and private for-profit hospitals. Methods A total of 64,171 inpatients (51,933 for pneumonia…